Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation.
Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation. J Biol Chem. 2004 Dec 10; 279(50):52465-72.
View in:
PubMed
subject areas
Amino Acid Sequence
Amino Acid Sequence
Animals
Animals
Base Sequence
Base Sequence
Binding Sites
Binding Sites
Cell Line
Cell Line
CHO Cells
CHO Cells
Cricetinae
Cricetinae
Dimerization
Dimerization
DNA
DNA
DNA-Binding Proteins
DNA-Binding Proteins
Immunoglobulin mu-Chains
Immunoglobulin mu-Chains
In Vitro Techniques
In Vitro Techniques
Mice
Mice
Molecular Sequence Data
Molecular Sequence Data
Mutagenesis, Site-Directed
Mutagenesis, Site-Directed
Oncogenes
Oncogenes
Protein Structure, Quaternary
Protein Structure, Quaternary
Protein Structure, Tertiary
Protein Structure, Tertiary
Recombinant Proteins
Recombinant Proteins
Trans-Activators
Trans-Activators
Transcription Factors
Transcription Factors
Transcriptional Activation
Transcriptional Activation
Transfection
Transfection
authors with profiles
Carol F Webb